Table 2. Immune and inflammatory blood markers at baseline, and during sleep restriction and recovery periods.
Baseline | Restriction 1 | Restriction 3 | Restriction 5 | Recovery 1 | Recovery 2 | Recovery 3 | P Value | |
Leukocytes(103cells/μl) | 6.77(5.58-7.32) | 7.2(5.92-7.85) | 6.86(6.47-7.43) | 7.40(6.30-8.22) | 7.10(5.95-7.76) | 6.50(6.07-8.30) | 6.70(5.97-7.90) | 0.36 |
Neutrophils(103cells/μl) | 3.56(2.66-4.13) | 3.76(2.96-4.63) | 3.72(3.34-4.02) | 3.96(3.28-4.34) | 3.58(3.21-4.05) | 3.79(2.70-4.57) | 3.42(2.97-4.45) | 0.19 |
Lymphocytes(103cells/μl) | 2.42(2.27-2.64) | 2.35(1.93-2.59) | 2.34(2.1-2.5) | 2.44(2.0-2.6) | 2.56(2.3-2.7) | 2.37(2.1-4.1) | 3.3(2.6-4.1) | 0.62 |
Monocytes(103cells/μl) | 0.55(0.49-0.62) | 0.61(0.53-0.72) | 0.56(0.51-0.68) | 0.61(0.51-0.72) | 0.57(0.52-0.66) | 0.65(0.49-0.74) | 0.65(0.50-0.71) | 0.18 |
Fibrinogen(mg/dl) | 2.76(2.49-2.98) | 2.95(2.71-3.07) | 2.78(2.54-2.98) | 2.71(2.41-2.94) | 2.72(2.39-2.99) | 2.74(2.47-2.95) | 2.90(2.44-3.18) | 0.13 |
Hs-CRP(mg/dl) | 0.09(0.07-0.11) | 0.10(0.06-0.14) | 0.08(0.06-0.09) | 0.08(0.05-0.09) | 0.08(0.06-0.09) | 0.06(0.06-0.09) | 0.07(0.05-0.11) | 0.11 |
Interleukin-8(pg/ml) | 4.70(4.34-6.00) | 6.36(4.33-6.00) | 4.78(3.39-5.86) | 4.68(4.03-6.91) | 5.88(4.59-9.61) | 6.60(3.75-10.457) | 4.36(3.61-5.48) | 0.11 |
ApoB (mg/dl) | 74.1(71.7-89.4) | 72.9(68.1-93.7) | 71.6(64.4-93.2) | 68.5(64.0-85.6) | 68.9(64.5-85.9) | 73.1(63.0-86.7) | 66.1*(64.0-84.9) | 0.007 |
Mox-LDL(µg/ml) | 8.1(3.35-11.50) | 12.3*(4.51-28.19) | 14.6*(4.47-23.03) | 10.3(4.40-11.92) | 9.2(3.51-12.73) | 8.8(3.47-14.19) | 6.8(4.87-11.11) | 0.002 |
IGF-1(pg/ml) | 0.95(0.72-1.09) | 0.88(0.69-1.23) | 0.97(0.66-1.40) | 0.95(0.76-1.22) | 1.18*(0.83-1.38) | 0.92(0.80-1.16) | 0.87(0.80-1.08) | 0.03 |
Values are shown as medians (25%–75% range). Baseline (average of the 3 baseline days for each volunteer) was used as control and other days as the comparative groups. Data comparisons with the baseline were performed using a Friedman Repeated Measures Analysis of Variance on Ranks and a Dunn's post-hoc test.
*Significant difference vs. baseline (P<0.05).